activity
20242026
collaborators

5 papers

stat.ML2026

Cost-optimal Sequential Testing via Doubly Robust Q-learning

Doudou Zhou, Yiran Zhang, Dian Jin +3

Clinical decision-making often involves selecting tests that are costly, invasive, or time-consuming, motivating individualized, sequential strategies for what to measure and when…

stat.ME2026

Nonparametric estimation of the total treatment effect with multiple outcomes in the presence of terminal events

Jessica Gronsbell, Zachary R. McCaw, Isabelle-Emmanuella Nogues +4

As standards of care advance, patients are living longer and once-fatal diseases are becoming manageable. Clinical trials increasingly focus on reducing disease burden, which can b…

stat.ME2025

Resilience Measures for the Surrogate Paradox

Emily Hsiao, Lu Tian, Layla Parast

Surrogate markers are often used in clinical trials to evaluate treatment effects when primary outcomes are costly, invasive, or take a long time to observe. However, reliance on s…

stat.ME2025

Sampling-based federated inference for M-estimators with non-smooth objective functions

Xiudi Li, Lu Tian, Tianxi Cai

We propose a novel sampling-based federated learning framework for statistical inference on M-estimators with non-smooth objective functions, which frequently arise in modern stati…

stat.ME2024

Model-free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival

Xuan Wang, Tianxi Cai, Lu Tian +1

Clinical trials or studies oftentimes require long-term and/or costly follow-up of participants to evaluate a novel treatment/drug/vaccine. There has been increasing interest in th…